IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX) in a research note released on Tuesday. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Trading Down 6.3 %

Shares of IRIX stock opened at $0.89 on Tuesday. The company has a market capitalization of $14.81 million, a P/E ratio of -1.33 and a beta of 0.94. The company has a current ratio of 1.54, a quick ratio of 0.85 and a debt-to-equity ratio of 0.55. The business’s 50 day moving average is $1.42 and its two-hundred day moving average is $1.61. IRIDEX has a twelve month low of $0.78 and a twelve month high of $3.65.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.